Literature DB >> 15345918

Influence of the type of membrane and heparin on serum lipid parameters during a dialysis session: a pilot study.

Konstantinos P Katopodis1, Moses Elisaf, Olga Balafa, Petros Nikolopoulos, Eleni Bairaktari, Afroditi Katsaraki, Kostas C Siamopoulos.   

Abstract

BACKGROUND/AIM: The type of heparin and membrane used might influence the lipids in patients on hemodialysis (HD). However, there are limited and debatable data concerning the lipid changes during an HD session. The aim of our study was to examine the changes in serum lipid parameters during the HD session in relation to the heparin and dialysis membrane used.
METHODS: Ten patients on HD 3 times/week participated in the study. The study was performed in three phases (A, B, C), each of 1 week's duration. The types of membranes used were Hemophan (phase A), ethylene vinyl alcohol (phase B) and polyacrylonitrile (phase C), respectively, in a random order. During the midweek session of each phase we used classic heparin, while during the session at the end of the week low molecular weight heparin was administered. Serum total cholesterol, triglycerides, HDL cholesterol, Lp(a), albumin and total proteins were measured before and 5 min after the HD and hourly during the HD session.
RESULTS: In all phases, we found a progressive increase in all lipid parameters during the HD session, except Lp(a). This increase, however, was possibly due to hemoconcentration.
CONCLUSIONS: This pilot study showed that (1) the type of heparin and membrane used does not seem to affect the serum lipid profile during a single HD procedure, and (2) the changes observed in serum lipid parameters are mainly due to hemoconcentration. 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15345918     DOI: 10.1159/000080591

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  2 in total

1.  The impact of haemodialysis-associated variables on lipid profile in Egyptian haemodialysis population.

Authors:  H Abo-Zenah; A Sabry; A Farouk; N Abdelhalim; K El-Sayed; M Sobh
Journal:  Int Urol Nephrol       Date:  2007-02-06       Impact factor: 2.266

2.  Dyslipidemia associated with chronic kidney disease.

Authors:  Vasilis Tsimihodimos; Zoi Mitrogianni; Moses Elisaf
Journal:  Open Cardiovasc Med J       Date:  2011-02-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.